Abstract
Breast cancer is the most prevalent female cancer in the world and its incidence is increasing, largely because of the Western lifestyle. There is a need, not only to predict women who will develop the disease, but also to apply drug and lifestyle measures in order to prevent the disease. Current risk prediction models are based on combinations of risk factors and have good predictive but low discriminatory power. New risk prediction methods might come from examination of single nucleotide polymorphisms in several genes or from an increased knowledge of the molecular and cellular biology of the breast, particularly with respect to aberrant gene expression and protein synthesis. These methods might also determine new targets for preventive agents and lifestyle change. Many potential preventive measures are available and some have been successful. New approaches are required, however, not only to prevent the disease but to devise methods for their assessment that do not require very large and expensive clinical trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parkin DM et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108
Cuzick J et al. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361: 296–300
Howard BA and Gusterson BA (2000) Human breast development. J Mammary Gland Biol Neoplasia 5: 119–137
Keeling JW et al. (2000) Oestrogen receptor alpha in female fetal, infant, and child mammary tissue. J Pathol 191: 449–451
Going JJ and Moffat DF (2004) Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol 203: 538–544
Hutson SW et al. (1985) Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38: 281–287
Brisson J et al. (1988) Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project. J Natl Cancer Inst 80: 1534–1540
Frantz VK et al. (1951) Incidence of chronic cystic disease in so-called “normal breasts”; a study based on 225 postmortem examinations. Cancer 4: 762–783
Sandison AT (1962) An autopsy study of the adult human breast: with special reference to proliferative epithelial changes of importance in the pathology of the breast. Natl Cancer Inst Monogr 4: 1–145
Freedman AN et al. (2005) Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 97: 715–723
Rockhill B et al. (2001) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93: 358–366
Amir E et al. (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40: 807–814
Wald NJ et al. (1999) When can a risk factor be used as a worthwhile screening test? BMJ 319: 1562–1565
Boyd NF et al. (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7: 1133–1144
Huang Z et al. (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278: 1407–1411
Key TJ et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95: 1218–1226
Pharoah PD et al. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33–36
Peto J and Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26: 411–414
Nielsen M (1989) Autopsy studies of the occurrence of cancerous, atypical and benign epithelial lesions in the female breast. APMIS 10 (Suppl): 1–56
Pharoah PD et al. (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4: 850–860
Martino S et al. (2004) Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 96: 1751–1761
Howell A et al. (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365: 60–62
Olson JE et al. (2004) Bilateral oophorectomy and breast cancer risk reduction among women with a family history. Cancer Detect Prev 28: 357–360
Harvie M et al. (2005) Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14: 656–661
Zhu Z et al. (2005) 2-deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Res 65: 7023–7030
Ingram DK et al. (2004) Development of calorie restriction mimetics as a prolongevity strategy. Ann NY Acad Sci 1019: 412–423
McTiernan A et al. (2003) Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 290: 1331–1336
Zhang Y et al. (2005) Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 162: 165–170
Kochhar R et al. (2005) Statins to reduce breast cancer risk: a case control study in US female veterans. In Proceedings of the American Society of Clinical Oncology Annual Meeting: 2005 May 13–17; Florida. ASCO
Bresalier RS et al. (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352: 1092–1102
Cook NR et al. (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47–55
Manson MM et al. (2005) Innovative agents in cancer prevention. Recent Results Cancer Res 166: 257–275
Shen Q and Brown PH (2003) Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J Mammary Gland Biol Neoplasia 8: 45–73
Wiseman BS and Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296: 1046–1049
Couldrey C et al. (2002) Adipose tissue: a vital in vivo role in mammary gland development but not differentiation. Dev Dyn 223: 459–468
Hu X et al. (2002) Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704–1711
Lewis MT et al. (1999) Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development 126: 5181–5193
Lewis MT (2001) Hedgehog signaling in mouse mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia 6: 53–66
Lai EC (2004) Notch signaling: control of cell communication and cell fate. Development 131: 965–973
Gallahan D and Callahan R (1997) The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 14: 1883–1890
Pece S et al. (2004) Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167: 215–221
Barcellos-Hoff MH and Ravani SA (2000) Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60: 1254–1260
Maffini MV et al. (2004) The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 117: 1495–1502
Wellings SR et al. (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55: 231–273
Lee S et al. (2005) Biological features and xenograft models of a very early human premalignant breast lesion. Breast Cancer Res 7 (Suppl 2): S17
Clarke RB et al. (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987–4991
Allred DC et al. (2004) The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 6: 240–245
Clarke RB et al. (2005) A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277: 443–456
Dontu G et al. (2004) Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 15: 193–197
Kennedy DO et al. (2005) DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 97: 127–132
Scott D (2004) Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 104: 365–370
Borresen-Dale AL and Sharma P (2005) Expression profiling of peripheral blood cells for early detection. Breast Cancer Res 7 (Suppl 2): S8
Gauthier ML et al. (2005) p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res 65: 1792–1799
Allan DJ et al. (1992) Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 167: 25–32
Khan SA et al. (1999) The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol. Cancer Epidemiol Biomarkers Prev 8: 867–872
Hassan HI and Walker RA (2001) Altered expression of epidermal growth factor receptor in non-involved tissue of cancer-containing breasts. Breast 10: 318–324
Deng G et al. (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057–2059
Guo YP et al. (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10: 243–248
Tlsty TD et al. (2005) Epigenetic and genetic changes control tumorigenic phenotypes and occur in vivo in human mammary epithelia. In Proceedings of Keystone Symposium: The Role of Microenvironment in Tumor Induction and Progression: 2005 February 5–10; Banff. Silverthorne: Keystone Symposia
Parrinello S et al. (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118: 485–496
Kuperwasser C et al. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101: 4966–4971
Iyengar P et al. (2005) Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 115: 1163–1176
Catalano S et al. (2004) Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem 279: 19908–19915
Coussens LM and Werb Z (2002) Inflammation and cancer. Nature 420: 860–867
Weisberg SP et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796–1808
Verlinden I et al. (2005) Parity-induced changes in global gene expression in the human mammary gland. Eur J Cancer Prev 14: 129–137
Perou CM et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747–752
Allinen M et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17–32
Chang HY et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102: 3738–3743
Shelton DN et al. (1999) Microarray analysis of replicative senescence. Curr Biol 9: 939–945
Clement K et al. (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18: 1657–1669
Greten FR et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285–296
Karin M et al. (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301–310
Luo Z et al. (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26: 69–76
Lamming DW et al. (2004) Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol 53: 1003–1009
Kalaitzidis D and Gilmore TD (2005) Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab 16: 46–52
deGraffenried LA et al. (2004) NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol 15: 885–890
Riggins RB et al. (2005) The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells. Mol Cancer Ther 4: 33–41
Kong G et al. (2005) The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention. Cancer Res 65: 3462–3469
Harper-Wynne C et al. (2002) Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. Cancer Epidemiol Biomarkers Prev 11: 614–621
Fabian CJ et al. (2005) Breast-tissue sampling for risk assessment and prevention. Endocr Relat Cancer 12: 185–213
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Howell, A., Sims, A., Ong, K. et al. Mechanisms of Disease: prediction and prevention of breast cancer—cellular and molecular interactions. Nat Rev Clin Oncol 2, 635–646 (2005). https://doi.org/10.1038/ncponc0361
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0361
This article is cited by
-
Performance analysis of machine learning based optimized feature selection approaches for breast cancer diagnosis
International Journal of Information Technology (2022)
-
Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Obesity Surgery (2016)
-
Breast tumour stroma is a prognostic indicator and target for therapy
Breast Cancer Research (2009)